Abstract:Long-term self-care plays a crucial role in the management of type 2 diabetes mellitus (T2DM). Central to this is adherence to hypoglycemic medications. However, it has been reported that between 36% and 93% of individuals with diabetes take their medications as prescribed. [ 1 ] Furthermore, higher HbA1c values are associated with poor adherence to oral hypoglycemic medications (OHAs), higher potential for hospitalization, and increased mortality. [ 2 , 3 ] Therefore, improving medication adherence is a major challenge in diabetes management. Medication adherence can be subjectively or objectively assessed. The average proportion of days covered and medication possession ratio are the main objective parameters used to evaluate OHAs. These measurements are based on information gathered from data on medication claims that record medication usage information billed to insurance companies by pharmacies, and the majority of reports use these measurements as objective measures. [ 4–8 ] However, they measured refill behavior only and could not confirm whether the patients actually took their medication, which has been acknowledged as a limitation in previous studies. [ 5–8 ] Previous studies using these measures have shown inconsistent results, reporting that various factors are associated with poor adherence, including age, the type of hypoglycemic agent, the number of these agents, and the number of daily dosages. [ 9 ] Conversely, pill counting, which is a technique for objective evaluation, has higher accuracy compared to other methods. [ 10 ] Pill counting provides more accurate information because the assessment is based on the patient's remaining medication. However, previous studies on pill counting adherence have described psychological bias and possible concealment by patients as limitations of their studies, since the purpose of the studies was to pill counting. [ 11–13 ] Additionally, medication adherence varies depending on who manages and helps patients take medications at home, that is, the patients themselves, their parents, spouses, children, or home care workers. Hence, it is essential to assess medication adherence under the conditions that mitigate this bias. We should investigate patients' self-adherence with pill counting in situations where patients have less psychological bias. We have previously reported the factors affecting a patient's medication adherence. In a scenario where the patient's psychological bias is low, pill counting using medical reconciliation can be performed using an assessment method that we defined as medication adherence values (MAVs). [ 14 ] In our previous study, at the time of hospitalization, we included patients who had been taking the same OHAs for more than 24 weeks. However, according to the findings of that study, there was no significant association between HbA1c and medication adherence. [ 14 ] For patients with diabetes, maintaining glycemic control with hypoglycemic agents can only be achieved through optimal medication adherence. Therefore, it is important to establish a connection between HbA1c levels and the factors affecting poor medication adherence. Herein, the duration of OHAs was extended to >48 weeks to investigate the impact of medication adherence on HbA1c levels. In addition, the factors affecting low medication adherence were identified.

Estimated Cost of Injectable Medication Waste Attributable to Syringe Dead Space.

Blood Glucose Control in Noncritically Ill Patients Is Associated With a Decreased Length of Stay, Readmission Rate, and Hospital Mortality

Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes

A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures

Reducing Diabetes Burden in Medtronic's Automated Insulin Delivery Systems

Risk of hypoglycaemia among people with type 2 diabetes not treated with insulin: A retrospective analysis of Medicare Advantage beneficiaries

Frequency of missed doses and its effects on the regulation of glucose levels in patients with type 2 diabetes: A retrospective analysis

Hemodialysis-Related Glycemic Disarray Proven by Continuous Glucose Monitoring; Glycemic Markers and Hypoglycemia

387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

EMERGE: Evaluating the value of Measuring Random Plasma Glucose Values for Managing Hyperglycemia in the Inpatient Setting

Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study

Impact of Age, Frailty, and Dementia on Prescribing for Type 2 Diabetes at Hospital Discharge 2012-2016

Impact of Hypoglycemia on Glucose Variability Over Time for Individuals with Open Source Automated Insulin Delivery Systems

Comparative efficacy and complications of long-acting and intermediate-acting insulin regimens for adults with type 1 diabetes: an individual patient data network meta-analysis

Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy

Leveraging Continuous Glucose Monitoring Data as an Additional Source for Glucagon Prescription Behavior

Rate of Inpatient Hypoglycemia Following a 1:1 Dose Interchange Between Concentrated Insulin Glargine to Insulin Detemir

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes

Effects of Glargine on the Levels of Malondialdehyde and Hs-Crp in Type 2 Diabetic Patients

Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey